Scientific Industries, Inc. has introduced a new AI-powered feature for its VIVID WORKSTATION, marking a significant advancement in automated pill counting and reinforcing the company’s strategic focus on high-growth technologies. The launch comes as the company reports a strong rebound in its third-quarter 2025 financial performance, driven largely by rising demand in its Torbal Division and gains from its recent Genie Division divestiture.
The new AI-enhanced capability brings improved accuracy, faster pill identification, and strengthened compliance to pharmacy automation. By integrating machine intelligence across hardware, firmware, and software, the upgrade delivers greater precision and cost efficiency for customers operating in high-volume environments.
“Our sharpened focus on high-growth segments—including our pill counting businessis already showing results,” said Helena Santos, CEO of Scientific Industries. “With the introduction of AI-driven capabilities in the VIVID WORKSTATION, we are redefining innovation in pharmacy automation. This upgrade enhances precision and accountability while providing meaningful operational savings for our customers.”
The company’s Q3 2025 financial report reflects renewed momentum. Net revenues rose 52.2 per cent to $1,404,000, driven by strong VIVID product demand within the Torbal Division. While Bioprocessing Systems Operations saw softer market conditions, overall profitability surged due to a $5.26 million gain from the Genie Division sale. Scientific Industries reported net income of $3,994,400 for the quarter, a dramatic turnaround from a $1,180,100 loss in Q3 2024.
For the nine months ended September 30, 2025, net revenues totalled $3,427,100, with Torbal revenues up 15 per cent year over year. The company also trimmed operating expenses by $439,600, contributing to improved performance.
Chairman John Moore highlighted ongoing innovation in the bioprocessing segment, including customer adoption of the new dissolved oxygen sensor and anticipation for upcoming pH sensor trials. Despite challenges such as tariffs and reduced research funding, the company remains optimistic about future growth.
The release of VIVID’s AI-powered feature further strengthens Scientific Industries’ positioning as a leader in automated pharmacy solutions.
